ECM
ANGO icon

Endurant Capital Management’s AngioDynamics ANGO Stock Holding History

Endurant Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-18,125
Closed -$500K – 64
2021
Q4 		$500K Buy
+18,125
New +$500K 0.12% 67
2021
Q2 		– Sell
-128,865
Closed -$3.02M – 60
2021
Q1 		$3.02M Sell
128,865
-56,036
-30% -$1.13M 0.79% 42
2020
Q4 		$2.83M Buy
+184,901
New +$2.35M 1.02% 34

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Endurant Capital Management's ANGO Position: Q1 2022 in Review

Endurant Capital Management sold out of AngioDynamics (ANGO) in Q1 2022, closing a stake of 18,125 shares — an estimated $500K sold.

Endurant Capital Management first reported a position in ANGO in Q4 2020 and held it in 3 quarters. The position peaked at $3.02M in Q1 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2022.

  • Endurant Capital Management reported no remaining AngioDynamics position as of Q1 2022 after selling out during the quarter.
  • Endurant Capital Management sold 18,125 AngioDynamics shares in Q1 2022, an estimated $500K.
  • Endurant Capital Management first reported a position in AngioDynamics in Q4 2020 and held it in 3 quarters.
  • Endurant Capital Management's AngioDynamics position peaked at $3.02M in Q1 2021.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2022.

Based on Endurant Capital Management's 13F filing for Q1 2022, filed 16 May 2022.